Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement

Clinical Efficacy and Side Effects

Published in: Evidence Report/Technology Assessment: no. 76 (Prepared by the Southern California/RAND Evidence-based Practice Center under contract No. 290-97-0001). AHRQ Publication No. 03-E022. Agency for Healthcare Research and Quality, Rockville, MD. Feb. 2003, 475 p

Posted on RAND.org on February 01, 2003

by Paul G. Shekelle, Sally C. Morton, Margaret A. Maglione, Mary L. Hardy, Walter Mojica, Marika Booth, Shannon Rhodes, Lara Hilton, James Gagne

Read More

Access further information on this document at www.ahrq.gov

This article was published outside of RAND. The full text of the article can be found at the link above.

At the direction of the funding agencies (the National Institutes of Health Office of Dietary Supplements (ODS), the National Center for Complementary and Alternative Medicine (NCCAM), and the Agency for Healthcare Research and Quality (AHRQ)), and in consultation with our Technical Expert Panel, the authors addressed research questions regarding the efficacy of herbal ephedra and ephedrine for weight loss and athletic performance through a comprehensive literature review and synthesis of evidence. They assessed the safety of these products through review of clinical trials. Meta-analysis was performed where appropriate. In addition, the authors reviewed herbal ephedra- and ephedrine-related adverse events reports on file with the U.S. Food and Drug Administration (FDA), published case reports, and reports to a manufacturer of ephedra-containing products. It is expected that the results of this review will be used to direct further research.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/research-integrity.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.